Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28% Market Closed
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Net Margin
Creo Medical Group PLC

-73.9%
Current
-79%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-73.9%
=
Net Income
-22.4m
/
Revenue
30.3m

Net Margin Across Competitors

Country UK
Market Cap 76.3m GBP
Net Margin
-74%
Country US
Market Cap 204.4B USD
Net Margin
14%
Country US
Market Cap 183.9B USD
Net Margin
29%
Country US
Market Cap 140.3B USD
Net Margin
16%
Country US
Market Cap 125.1B USD
Net Margin
11%
Country IE
Market Cap 114.5B USD
Net Margin
12%
Country US
Market Cap 68.3B USD
Net Margin
7%
Country DE
Market Cap 54B EUR
Net Margin
8%
Country CN
Market Cap 338.2B CNY
Net Margin
34%
Country US
Market Cap 40B USD
Net Margin
9%
Country US
Market Cap 39.9B USD
Net Margin
74%

Profitability Report

View the profitability report to see the full profitability analysis for Creo Medical Group PLC.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-73.9%
=
Net Income
-22.4m
/
Revenue
30.3m
What is the Net Margin of Creo Medical Group PLC?

Based on Creo Medical Group PLC's most recent financial statements, the company has Net Margin of -73.9%.